Developing innovative ocular solutions
Nicox is an international ophthalmology company developing innovative therapeutics to help maintain vision and improve ocular health.
We plan to keep the maximum of options open for the company by maintaining rights to our novel therapeutics for eye diseases in key territories, such as the U.S. and Europe, as we create value by advancing their development, maintaining the potential for direct marketing, licensing for certain territories and growth through strategic transactions.
We are focused on the discovery, development and commercialization of novel ophthalmic therapeutics for eye diseases.
1996
Served areaWorldwide
Headcount32
HeadquartersDrakkar 2 - Bรขtiment D 2405 Route des Dolines, 6560 Valbonne โ France
43,223,135
IPODec. 29, 2000
Stock exchange(s)Euronext Paris